---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-180814"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T12:47:15.261042+00:00"
event_type: "other"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics Regains Nasdaq Compliance; Reports $3M Stockholders' Equity and $35M+ MVLS

## Summary
- Reported stockholders' equity of $3M as of June 30, 2025, satisfying Nasdaq's minimum $2.5M Equity Rule.
- Sold over $2M in common stock via a $50M equity line of credit with Lincoln Park Capital Fund since June 30.
- As of August 13, 2025, market value of listed securities exceeded $35M for 20 consecutive business days, meeting the alternative MVLS requirement.
- Company awaits formal Nasdaq confirmation that it has evidenced compliance with either or both listing standards.

## SEC filing metadata
- accession: 0001193125-25-180814
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: other
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/0001193125-25-180814-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000119312525180814/d824499d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-180814
- JSON: https://secwatch.observer/filing/0001193125-25-180814.json
- Plain text: https://secwatch.observer/filing/0001193125-25-180814.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.